Rankings
▼
Calendar
ARGX Q3 2024 Earnings — argenx SE Revenue & Financial Results | Market Cap Arena
ARGX
argenx SE
$46B
Q3 2024 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$573M
+73.8% YoY
Gross Profit
$514M
89.7% margin
Operating Income
$14M
2.5% margin
Net Income
$91M
15.9% margin
EPS (Diluted)
$1.39
QoQ Revenue Growth
-36.4%
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$573M
$330M
+73.8%
Gross Profit
$514M
$294M
+75.0%
Operating Income
$14M
-$81M
+117.6%
Net Income
$91M
-$73M
+225.8%
← FY 2024
All Quarters
Q4 2024 →